How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

339,324 results for

cardio*

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study Full Text available with Trip Pro

Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please (...) , Elizabeth M Hensor 2, 4 , Sue Pavitt 5 , Maya H Buch 2, 6, 7, * 1 Department of Biomedical Imaging Science, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK 2 Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK 3 Department of Specialist Science Education, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK 4 National Institute for Health Research Leeds Biomedical Research Centre, Leeds

2021 NIHR HTA programme

2. Implementation of interventions to reduce preventable hospital admissions for cardiovascular or respiratory conditions: an evidence map and realist synthesis Full Text available with Trip Pro

Implementation of interventions to reduce preventable hospital admissions for cardiovascular or respiratory conditions: an evidence map and realist synthesis Implementation of interventions to reduce preventable hospital admissions for cardiovascular or respiratory conditions: an evidence map and realist synthesis Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found (...) . Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Factors facilitating implementation of interventions to reduce avoidable admissions for cardiovascular and respiratory conditions can be identified at a patient, general practitioner and health system level. {{author}} {{($index , & . Duncan Chambers * , Anna Cantrell, Andrew Booth School

2020 NIHR HTA programme

3. Enhanced motivational interviewing for reducing weight and increasing physical activity in adults with high cardiovascular risk: the MOVE IT three-arm RCT Full Text available with Trip Pro

Enhanced motivational interviewing for reducing weight and increasing physical activity in adults with high cardiovascular risk: the MOVE IT three-arm RCT Enhanced motivational interviewing for reducing weight and increasing physical activity in adults with high cardiovascular risk: the MOVE IT three-arm RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please (...) choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Enhanced motivational interviewing, in group or individual formats, did not reduce weight or increase physical activity in adults with high cardiovascular disease risk. {{author}} {{($index , , , , , , , , , , , , , , & . Khalida Ismail 1, * , Daniel Stahl 2 , Adam Bayley 1 , Katherine Twist 1 , Kurtis

2020 NIHR HTA programme

4. Promoting patient utilization of outpatient cardiac rehabilitation: a joint International Council and Canadian Association of Cardiovascular Prevention and Rehabilitation position statement

Cardiovascular Health and Rehabilitation Association, Brazilian Association of Cardiorespiratory and Intensive Care Physiotherapy, Brazilian Group of Cardiopulmonary and Metabolic Rehabilitation, British Association for Cardiovascular Prevention and Rehabilitation, Canadian Association of Cardiovascular Prevention and Rehabilitation, Canadian Cardiovascular Society, Canadian Council of Cardiovascular Nurses, Cardiac Health Foundation of Canada, Cardiac Society Brunei Darussalam, Indonesian Heart Association (...) Promoting patient utilization of outpatient cardiac rehabilitation: a joint International Council and Canadian Association of Cardiovascular Prevention and Rehabilitation position statement Promoting Patient Utilization of Outpatient Cardiac Rehabili... : Journal of Cardiopulmonary Rehabilitation and Prevention ')} You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page. Your account has been temporarily locked Your account has been

2020 CPG Infobase

5. Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT Full Text available with Trip Pro

Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from (...) the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This research programme developed new ways of predicting cardiovascular disease risk for people with severe mental illnesses, but an evidence-based practitioner-led intervention in primary care did not reduce cholesterol more than treatment as usual. {{author}} {{($index , , , , , , , , , , , , , , , , , , , , , , , , , & . David

2019 NIHR HTA programme

6. Promoting patient utilization of outpatient cardiac rehabilitation: A joint International Council and Canadian Association of Cardiovascular Prevention and Rehabilitation position statement Full Text available with Trip Pro

them to complete programs. Previous article in issue Next article in issue Keywords Coronary artery disease Secondary prevention Health services accessibility Disease management Cardiac rehabilitation Recommended articles Citing articles (0) Endorsed by: American Society for Preventive Cardiology, Association Francophone de Cardiologie Préventive, Australian Cardiovascular Health and Rehabilitation Association, Brazilian Association of Cardiorespiratory and Intensive Care Physiotherapy, Brazilian (...) Group of Cardiopulmonary and Metabolic Rehabilitation, British Association for Cardiovascular Prevention and Rehabilitation, Canadian Association of Cardiovascular Prevention and Rehabilitation, Canadian Cardiovascular Society, Canadian Council of Cardiovascular Nurses, Cardiac Health Foundation of Canada, Cardiac Society Brunei Darussalam, Indonesian Heart Association, International Council of Cardiovascular Prevention and Rehabilitation, International Society of Physical and Rehabilitation

2020 CPG Infobase

7. A national registry to assess the value of cardiovascular magnetic resonance imaging after primary percutaneous coronary intervention pathway activation: a feasibility cohort study Full Text available with Trip Pro

A national registry to assess the value of cardiovascular magnetic resonance imaging after primary percutaneous coronary intervention pathway activation: a feasibility cohort study A national registry to assess the value of cardiovascular magnetic resonance imaging after primary percutaneous coronary intervention pathway activation: a feasibility cohort study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry (...) , , , , , , , , , , & . Jessica M Harris 1 , Rachel C Brierley 1 , Maria Pufulete 1 , Chiara Bucciarelli-Ducci 2 , Elizabeth A Stokes 3 , John P Greenwood 4 , Stephen H Dorman 2 , Richard A Anderson 5 , Chris A Rogers 1 , Sarah Wordsworth 3 , Sunita Berry 6 , Barnaby C Reeves 1, * 1 Clinical Trials and Evaluation Unit, Bristol Trials Centre, University of Bristol, Bristol, UK 2 National Institute for Health Research (NIHR) Bristol Cardiovascular Research Unit, Bristol Heart Institute, University of Bristol, Bristol, UK 3

2019 NIHR HTA programme

8. Ezetimibe for the prevention of cardiovascular Events

Ezetimibe for the prevention of cardiovascular Events 1 Translation of the executive summary of the rapid report A18-83 Ezetimib zur Prävention kardiovaskulärer Ereignisse (Version 2.0; Status: 3 September 2019). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Extract IQWiG Reports – Commission No. A18-83 Ezetimibe for the prevention of cardiovascular events 1 (...) Extract of rapid report A18-83 Version 2.0 Ezetimibe for the prevention of cardiovascular events 3 September 2019 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Ezetimibe for the prevention of cardiovascular events Commissioning agency: Federal Joint Committee Commission awarded on: 22 November 2018 Internal Commission No.: A18-83 Address of publisher: Institut für Qualität und

2020 Institute for Quality and Efficiency in Healthcare (IQWiG)

9. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation Full Text available with Trip Pro

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation - Canadian Journal of Cardiology Go search Please enter a term before submitting your search. , P1847-1948, December 01, 2020 Powered By Mendeley Share on The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm (...) , and survival. The contemporary management of AF is centred on symptomatic improvement, diminution in morbidity and mortality (particularly the prevention of cardiomyopathy, and stroke/systemic embolism), and reduction in AF-related emergency department (ED) visits or hospitalizations ( ). Figure 1 General overview of the management of atrial fibrillation (AF). CHADS-65, Canadian Cardiovascular Society algorithm; ED, emergency department; OAC, oral anticoagulation; LV, left ventricular; QOL, quality of life

2021 Canadian Cardiovascular Society

10. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis Full Text available with Trip Pro

level) held some promise in the field. Despite being less effective than amiodarone (AF recurrence during a median of 7 months after successful cardioversion was 63.5% with dronedarone versus 42.0% with amiodarone; P < 0.01; ), the results of dronedarone in the ATHENA trial ( ), led to enthusiasm concerning this novel antiarrhythmic agent. This drug was associated with a reduction in the primary study endpoint of first hospitalisation due to cardiovascular effects or death (hazard ratio (HR) 0.76 (...) as a result of the arrhythmia, it is performed urgently. However, more frequently, cardioversions are performed in stable patients on an elective basis ( ). Possible complications include skin burn or skin irritation (for electrical cardioversion), muscle pain (for electrical cardioversion), sedation‐related complications, proarrhythmia (unsynchronised cardioversion or drug‐induced tachyarrhythmias), bradycardias (in case of severe sinus node disease), and postcardioversion cardiogenic shock or acute

2019 Cochrane Database of Systematic Reviews

11. Reduction in saturated fat intake for cardiovascular disease. (Abstract)

Reduction in saturated fat intake for cardiovascular disease. Reducing saturated fat reduces serum cholesterol, but effects on other intermediate outcomes may be less clear. Additionally, it is unclear whether the energy from saturated fats eliminated from the diet are more helpfully replaced by polyunsaturated fats, monounsaturated fats, carbohydrate or protein.To assess the effect of reducing saturated fat intake and replacing it with carbohydrate (CHO), polyunsaturated (PUFA (...) ), monounsaturated fat (MUFA) and/or protein on mortality and cardiovascular morbidity, using all available randomised clinical trials.We updated our searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid) and Embase (Ovid) on 15 October 2019, and searched Clinicaltrials.gov and WHO International Clinical Trials Registry Platform (ICTRP) on 17 October 2019.Included trials fulfilled the following criteria: 1) randomised; 2) intention to reduce saturated fat intake OR intention

2020 Cochrane

12. Mechanical assist devices for acute cardiogenic shock. (Abstract)

Mechanical assist devices for acute cardiogenic shock. Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion due to a primary cardiac disorder. For people with refractory CS despite maximal vasopressors, inotropic support and intra-aortic balloon pump, mortality approaches 100%. Mechanical assist devices provide mechanical circulatory support (MCS) which has the ability to maintain vital organ perfusion, to unload the failing ventricle thus reduce intracardiac filling pressures (...) which reduces pulmonary congestion, myocardial wall stress and myocardial oxygen consumption. This has been hypothesised to allow time for myocardial recovery (bridge to recovery) or allow time to come to a decision as to whether the person is a candidate for a longer-term ventricular assist device (VAD) either as a bridge to heart transplantation or as a destination therapy with a long-term VAD.To assess whether mechanical assist devices improve survival in people with acute cardiogenic shock.We

2020 Cochrane

13. Chelation therapy for atherosclerotic cardiovascular disease. (Abstract)

Chelation therapy for atherosclerotic cardiovascular disease. Chelation therapy is promoted and practiced around the world as a form of alternative medicine in the treatment of atherosclerotic cardiovascular disease. It has been suggested as a safe, relatively inexpensive, non-surgical method of restoring blood flow in atherosclerotic vessels. However, there is currently limited high-quality, adequately-powered research informing evidence-based medicine on the topic, specifically regarding (...) clinical outcomes. Due to this limited evidence, the benefit of chelation therapy remains controversial at present. This is an update of a review first published in 2002.To assess the effects of ethylene diamine tetra-acetic acid (EDTA) chelation therapy versus placebo or no treatment on clinical outcomes among people with atherosclerotic cardiovascular disease.For this update, the Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, Cochrane Central Register

2020 Cochrane

14. Reduction in saturated fat intake for cardiovascular disease. (Abstract)

Reduction in saturated fat intake for cardiovascular disease. Reducing saturated fat reduces serum cholesterol, but effects on other intermediate outcomes may be less clear. Additionally, it is unclear whether the energy from saturated fats eliminated from the diet are more helpfully replaced by polyunsaturated fats, monounsaturated fats, carbohydrate or protein.To assess the effect of reducing saturated fat intake and replacing it with carbohydrate (CHO), polyunsaturated (PUFA (...) ), monounsaturated fat (MUFA) and/or protein on mortality and cardiovascular morbidity, using all available randomised clinical trials.We updated our searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid) and Embase (Ovid) on 15 October 2019, and searched Clinicaltrials.gov and WHO International Clinical Trials Registry Platform (ICTRP) on 17 October 2019.Included trials fulfilled the following criteria: 1) randomised; 2) intention to reduce saturated fat intake OR intention

2020 Cochrane

15. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. (Abstract)

Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. This is the second update of the review first published in 2017. Hypertension is a prominent preventable cause of premature morbidity and mortality. People with hypertension and established cardiovascular disease are at particularly high risk, so reducing blood pressure to below standard targets may be beneficial. This strategy could reduce cardiovascular mortality and morbidity but could also (...) increase adverse events. The optimal blood pressure target in people with hypertension and established cardiovascular disease remains unknown.To determine if lower blood pressure targets (135/85 mmHg or less) are associated with reduction in mortality and morbidity as compared with standard blood pressure targets (140 to 160/90 to 100 mmHg or less) in the treatment of people with hypertension and a history of cardiovascular disease (myocardial infarction, angina, stroke, peripheral vascular occlusive

2020 Cochrane

16. 2021 CCS Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

2021 CCS Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult - Canadian Journal of Cardiology Login to your account Email/Username Password Remember me Don’t have an account? If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You (...) will then receive an email that contains a secure link for resetting your password Email* If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password Go search Please enter a term before submitting your search. Powered By Mendeley Share on 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult Author Footnotes ⁎ These authors were co-chairs of this guideline update

2021 Canadian Cardiovascular Society

17. Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death

Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death Subcutaneous implantable cardio Subcutaneous implantable cardiov verter erter defibrillator insertion for pre defibrillator insertion for prev venting sudden enting sudden cardiac death cardiac death Interventional procedures guidance Published: 20 December 2017 nice.org.uk/guidance/ipg603 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful (...) details about all patients having subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death onto a register by submitting data to the National Audit of Cardiac Rhythm Management database at the UK National Institute for Cardiovascular Outcomes Research (NICOR), and should review local clinical outcomes. 1.3 The procedure should only be done by clinicians with specific training on inserting the device. 2 2 Indications and current treatments Indications

2018 National Institute for Health and Clinical Excellence - Interventional Procedures

18. Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death

Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death Published March 2020 Volume 20, Number 3 ONTARIO HEALTH TECHNOLOGY ASSESSMENT SERIES Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment KEY MESSAGES What Is This Health Technology Assessment About? Heart failure is a condition in which the heart’s ability to pump enough blood to meet the body’s needs is reduced. Heart failure can occur (...) cardiocirculatory death (when the heart has stopped beating and there is no longer blood flow or a pulse). We looked at the budget impact of publicly funding this system for adult heart transplant recipients in Ontario. We also looked at the experiences, preferences, and values of people waiting for a heart transplant, people who had received a heart transplant, and family members of organ donors. What Did This Health Technology Assessment Find? Outcomes for people who received hearts donated after

2020 Health Quality Ontario

19. COVID-19 and the cardiovascular system Full Text available with Trip Pro

COVID-19 and the cardiovascular system COVID-19 and the cardiovascular system | Nature Reviews Cardiology Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. A Nature Research Journal COVID-19 and the cardiovascular (...) , J. F. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395 , 514–523 (2020). 10. Sakabe, M., Yoshioka, R. & Fujiki, A. Sick sinus syndrome induced by interferon and ribavirin therapy in a patient with chronic hepatitis C. J. Cardiol. Cases 8 , 173–175 (2013). Author information Affiliations Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

2020 Covid-19 Ad hoc papers

20. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Full Text available with Trip Pro

, as cardiologists, we are also concerned about whether patients with cardiovascular disease are at greater risk for 2019-nCoV, and whether new coronavirus infections have an impact on the cardiovascular system. Previous studies have shown a relationship between cardiovascular metabolic diseases and SARS and MERS [ , , ]. A systematic analysis of 637 MERS-CoV cases showed that diabetes and hypertension are prevalent in about 50% of the patients and cardiac diseases are present in 30% of the cases [ ]. Diabetes (...) of SARS-CoV, It can be speculated that 2019-ncov infection may affect the cardiovascular system through multiple mechanisms. First, viral infection directly causes damage to cardiomyocyte. According to Oudit’s study, SARS-CoV viral RNA was detected in 35% of autopsied human heart samples from SARS-CoV infected patients during the Toronto SARS outbreak [ ]. And they also confirmed that pulmonary infection with the human SARS-CoV in mice led to an ACE2-dependent myocardial infection [ ]. ACE2

2020 Covid-19 Ad hoc papers

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>